Company

Novasenta

Biotechnology Research 350 Technology Dr 18 employees

Employees: 18
Contacts: 3
Emails: 3
Phones: 2

LinkedIn Crunchbase

Novasenta Overview

Headquarters: 350 Technology Dr
Industry: Biotechnology Research
Employees: 18
Founded: 2019
Funding: 15.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

healthcare cancer biotech immunology metabolism therapeutics

About Novasenta

Novasenta discovers novel therapeutic targets to develop innovative and effective treatments with the goal of transforming the lives of patients with cancer. We use systematic, rigorous, and unbiased human tumor microenvironment analysis to uncover new druggable targets, exploiting the critical interplay of disease, immune response, and metabolism. Single-cell level analysis of high-quality, human tumor samples combined with the advanced data mining abilities of our research and computational biology teams accelerate the path from discovery to patient. Our goal is to identify novel targets to generate effective therapies for a range of cancers.

Novasenta Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

Novasenta Org Chart

Sample employees and titles

Name	Title	Location	Contact
Q. Melody Dai, Ph.d., PMP, Rac	Expertise in Pharmaceuticals & Gene	New York City Metropolitan Area, United States	View
David Len Elion, Ph.d.	Senior Scientist in Drug Discovery	San Francisco Bay Area, United States	Email
Matthias Kleinz	Life Science Investor and Executive	Pittsburgh, Pennsylvania, United States	Email Phone
Patrick Mckiernan	Director, Finance at Novasenta	Pittsburgh, Pennsylvania, United States	Email Phone